# Alamar Biosciences, Inc. (ALMR)

> Source: Nexqual · https://nexqual.com/ALMR · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Alamar Biosciences, Inc. (ALMR), nexqual.com/ALMR" · informational, not investment advice.

**Price:** USD 27.42 (+8.08% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 25.37 · day 25.11–28.35 · 52w 18.85–39.61 · market cap $1.90B · NMS

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (5 analysts), mean target USD 35.4 (range 31–45).
- Total return with dividends: 1Y +24.6% vs S&P 500 +18.1%; 5Y +24.6% vs S&P 500 +85.1%.
- Next earnings: 2026-11-03, EPS estimate USD -0.19, revenue estimate $30.2M.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 5 analysts; mean target USD 35.4 (low 31, high 45).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | Stifel | Target raised | Buy | $28 → $32 |
| 2026-08-11 | JP Morgan | Target raised | Overweight | $32 → $35 |

## Total return (dividends reinvested)
|  | 1Y (from 2026-04-17) | 5Y (from 2026-04-13) |
|---|---|---|
| Total return | +24.6% | +24.6% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | — | — |
| Volatility (annualized) | 84.1% | 79.1% |
| Max drawdown | -38.3% (Oct 2026→Oct 2026) | -27.5% (Sep 2026→Oct 2026) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99% · TMDX (TransMedics Group, Inc.) USD 76.52 -3.30%

## More
Full page: https://nexqual.com/ALMR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt